Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Multiple Sclerosis and Related Disorders
|
March 16, 2024
Characteristics and predictors of sexual dysfunction in men with multiple sclerosis
Ivan Adamec, Tomislav Sambolić, Mihovil Santini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 4, 2021
Effectiveness and safety of alemtuzumab in the treatment of active relapsing-remitting multiple sclerosis: a multicenter, observational study
Gregor Brecl Jakob, Barbara Barun, Sarah Gomezelj, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
September 14, 2018
Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue
Magdalena Krbot Skorić, Luka Crnošija, Ivan Adamec, et al.
Multiple Sclerosis and Related Disorders
|
September 21, 2025
The impact of national policies on reimbursement of disease-modifying therapies for multiple sclerosis on disease outcomes: Slovenia versus Croatia
Gregor Brecl Jakob, Magdalena Krbot Skorić, Ivan Adamec, et al.
Multiple Sclerosis and Related Disorders
|
November 23, 2019
Intravenous immunoglobulins for the prevention of postpartum relapses in multiple sclerosis
Alenka Horvat Ledinek, Gregor Brecl Jakob, Jana Jerše, et al.
Multiple Sclerosis and Related Disorders
|
March 26, 2026
Long-term outcomes of cladribine tablets in multiple sclerosis: Treatment completion, persistence, and subsequent therapy transitions in Southeast Europe
Magdalena Krbot Skorić, Gregor Brecl Jakob, Cecilia Rajda, et al.
Multiple Sclerosis and Related Disorders
|
July 24, 2024
Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric study
Magdalena Krbot Skorić, Vanja Bašić Kes, Nevena Grbić, et al.
Journal of Neuroimmunology
|
August 21, 2021
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study
Mario Habek, Gregor Jakob Brecl, Vanja Bašić Kes, et al.
Journal of Neuroimmunology
|
August 3, 2023
Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers
Ivan Adamec, Gregor Brecl Jakob, Cecilia Rajda, et al.
European Journal of Neurology
|
May 22, 2022
Sudomotor dysfunction in people with neuromyelitis optica spectrum disorders
Mario Habek, Marko Andabaka, Alessandra Fanciulli, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Multiple Sclerosis and Related Disorders
|
March 16, 2024
Characteristics and predictors of sexual dysfunction in men with multiple sclerosis
Ivan Adamec, Tomislav Sambolić, Mihovil Santini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 4, 2021
Effectiveness and safety of alemtuzumab in the treatment of active relapsing-remitting multiple sclerosis: a multicenter, observational study
Gregor Brecl Jakob, Barbara Barun, Sarah Gomezelj, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|
September 14, 2018
Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue
Magdalena Krbot Skorić, Luka Crnošija, Ivan Adamec, et al.
Multiple Sclerosis and Related Disorders
|
September 21, 2025
The impact of national policies on reimbursement of disease-modifying therapies for multiple sclerosis on disease outcomes: Slovenia versus Croatia
Gregor Brecl Jakob, Magdalena Krbot Skorić, Ivan Adamec, et al.
Multiple Sclerosis and Related Disorders
|
November 23, 2019
Intravenous immunoglobulins for the prevention of postpartum relapses in multiple sclerosis
Alenka Horvat Ledinek, Gregor Brecl Jakob, Jana Jerše, et al.
Multiple Sclerosis and Related Disorders
|
March 26, 2026
Long-term outcomes of cladribine tablets in multiple sclerosis: Treatment completion, persistence, and subsequent therapy transitions in Southeast Europe
Magdalena Krbot Skorić, Gregor Brecl Jakob, Cecilia Rajda, et al.
Multiple Sclerosis and Related Disorders
|
July 24, 2024
Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric study
Magdalena Krbot Skorić, Vanja Bašić Kes, Nevena Grbić, et al.
Journal of Neuroimmunology
|
August 21, 2021
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study
Mario Habek, Gregor Jakob Brecl, Vanja Bašić Kes, et al.
Journal of Neuroimmunology
|
August 3, 2023
Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers
Ivan Adamec, Gregor Brecl Jakob, Cecilia Rajda, et al.
European Journal of Neurology
|
May 22, 2022
Sudomotor dysfunction in people with neuromyelitis optica spectrum disorders
Mario Habek, Marko Andabaka, Alessandra Fanciulli, et al.
Page
of 6